Press release
Hepatitis Therapeutics Market Trends That Will Shape the Next Decade: Insights from Advancing Hepatitis Therapeutics: Recent Innovations And Fda Approval Of Vemlidy By Gilead Sciences, Inc
Hepatitis Therapeutics
How Large Will the Hepatitis Therapeutics Market Size By 2025?
The market size for hepatitis therapeutics has seen consistent growth over the years. There is an anticipated rise from $18.66 billion in 2024 to $19.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.2%. Factors like vaccine creation, antiviral drugs, initiatives in public health, funding for research, and budding therapies are the primary reasons for this historical growth.
How Big Is the Hepatitis Therapeutics Market Size Expected to Grow by 2029?
In the coming years, the market size for hepatitis therapeutics is predicted to experience stable expansion, with estimates pegging its value at $22.75 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.2%. This growth over the forecast period can be attributed to various factors such as ongoing research and development, worldwide health initiatives, changes in patient care, government policies, and increasing awareness of the disease. The forecast period also expects significant trends like patient advocacy and support, continuous observation and follow-up interventions, healthcare fairness, telehealth and remote care, with a particular emphasis on the eradication of hepatitis C.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report
Which Key Market Drivers Powering Hepatitis Therapeutics Market Expansion and Growth?
The global increase in hepatitis infections is projected to drive the growth of hepatitis therapeutics market. This surge in hepatitis cases is attributed to factors such as limited access to healthcare services and vaccines, growing instances of intravenous drug consumption, unsafe practices of blood transfusion, and substandard sanitation and hygiene conditions in certain areas of the world. For example, the World Health Organization (WHO), a US-based public health agency of the United Nations, reported in April 2022 that at least 169 cases of acute hepatitis of unidentified origin were recorded in 11 countries, and a staggering 350 million people globally suffer from viral hepatitis B or C. However, the majority still struggle to access appropriate testing and treatment facilities. Hence, these factors are contributing to the expansion of the hepatitis therapeutics market due to the escalation in hepatitis infections.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9956&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Hepatitis Therapeutics Market?
Product innovation is becoming a significant trend in the hepatitis therapeutics market, with major companies creating new products to maintain their market presence. An example of this is when Gilead Sciences, Inc., a biopharmaceutical company based in the US, received FDA approval in November 2022 for a drug named Vemlidy (tenofovir alafenamide), for the treatment of pediatric patients with chronic hepatitis B virus infection. Vemlidy is a prodrug of tenofovir, which in 2016 got FDA approval as a daily treatment for individuals with chronic hepatitis B virus (HBV) infection and compensated liver disease. The American Liver Foundation has recommended it as a preferred or primary treatment for people with chronic HBV and compensated liver disease.
What Are the Emerging Segments in the Hepatitis Therapeutics Market?
The hepatitis therapeutics market covered in this report is segmented -
1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Drug Class: Oral Antivirals, Immune Modulators
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Hepatitis A: Vaccines, Post-Exposure Prophylaxis (PEP)
2) By Hepatitis B: Antiviral Medications, Immune Modulators, Vaccines
3) By Hepatitis C: Direct-Acting Antivirals (DAAs), Ribavirin, Interferon-Based Therapies
4) By Other Disease Types: Hepatitis D, Hepatitis E, Other Viral Hepatitis Infections
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9956&type=smp
Who Are the Global Leaders in the Hepatitis Therapeutics Market?
Major companies operating in the hepatitis therapeutics market include Gilead Sciences Inc., Bristol-Myers Squibb Co., AbbVie Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Cipla Inc., F Hoffmann-La Roche Ltd., Biocon Limited, LAURUS Labs Ltd., Zydus Lifesciences Limited, Hetero Healthcare Limited, Novartis AG, Sanofi SA, GlaxoSmithKline plc, Lupin Ltd., Teva Pharmaceutical Industries Ltd., NATCO Pharma Limited, Pfizer Inc., AstraZeneca plc, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Biocon Biopharmaceuticals Pvt. Ltd.
Which are the Top Profitable Regional Markets for the Hepatitis Therapeutics Industry?
North America was the largest region in the hepatitis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hepatitis therapeutics market report during the forecast period. The regions covered in the hepatitis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9956
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis Therapeutics Market Trends That Will Shape the Next Decade: Insights from Advancing Hepatitis Therapeutics: Recent Innovations And Fda Approval Of Vemlidy By Gilead Sciences, Inc here
News-ID: 4089059 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
